{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Bridgewater",
      "address_1": "400 Somerset Corporate Blvd",
      "reason_for_recall": "Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.",
      "address_2": "",
      "product_quantity": "3827 bottles",
      "code_info": "Lot #'s P0230-022R, P0230-023R, Exp 06/17",
      "center_classification_date": "20160615",
      "distribution_pattern": "Nationwide",
      "state": "NJ",
      "product_description": "Lodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ  08807, UPC 0 00950 86006 8.",
      "report_date": "20160622",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Valeant Pharmaceuticals North America LLC",
      "recall_number": "D-1032-2016",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "74223",
      "termination_date": "20170912",
      "more_code_info": "",
      "recall_initiation_date": "20160523",
      "postal_code": "08807-2867",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}